(Q81151717)

English

Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes

scientific article published on 05 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Nadja Thönes

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Martin Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

5 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

369

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

375-388

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Oral vaccines: new needs, new possibilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Production of human papillomavirus type 16 virus-like particles in transgenic plants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Efficient intracellular assembly of papillomaviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Genetic component in the inflammatory response induced by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Therapeutic vaccines for human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Mucosal vaccination strategies for women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Edible vaccines: current status and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Improvement of the systemic prime/oral boost strategy for systemic and local responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Prophylactic human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Induction of mucosal immune responses in the human genital tract.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Chimeric papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Chapter 1: HPV in the etiology of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Comparison of acute endotoxin-induced lesions in A/J and C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Crude saponins improve the immune response to an oral plant-made measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Estimates of the world-wide prevalence of cancer for 25 sites in the adult population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

A human papillomavirus type 16 vaccine by oral delivery of L1 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Delivering on the promise: HPV vaccines and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Genetic contribution to the septic response in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

The immunophysiological impact of bacterial CpG DNA on the gut.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.08.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2007.08.004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17822733%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81151717&oldid=1688406417"